Top Markets
#1 TENDIES TENDIES +59.67%
#2 Threshold Network Threshold Network +58.79%
#3 Cash Cat Cash Cat +21.23%
#4 OSK OSK +15.93%
#5 Magma Finance Magma Finance +13.61%
#6 Falcon Finance Falcon Finance +12.83%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 Kite Kite +11.86%
#9 Maple Finance Maple Finance +11.45%
#10 Asteroid Shiba Asteroid Shiba +9.44%
Coin of the day
TENDIES TENDIES
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Rankning i aktier #17292
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Aktiekurs
$1.35
Senast synkroniserad: 2026-09-01
Marknadsvärde
$249.21M
Förändring (1 dag)
1.13%
Förändring (1 år)
-22.70%
Land
US
Handel Neumora Therapeutics, Inc. Common Stock (NMRA)

Kategori

Healthcare
Aktiekurshistorik för Neumora Therapeutics, Inc. Common Stock (NMRA)
Högsta slutkurs: $1.33 den 2026-09-01

Lägsta slutkurs: $12.50 den 2023-09-01
Aktiekurshistorik för Neumora Therapeutics, Inc. Common Stock från 2023 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 4.86%
2025 -81.20%
2024 -26.84%
2023 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.65 36.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.60%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $154.27 537.74%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.79 8.50%
CH